Anectine (Sandoz Inc)
Welcome to the PulseAid listing for the Anectine drug offered from Sandoz Inc. This Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Succinylcholine Chloride |
SUBSTANCE NAME: | SUCCINYLCHOLINE CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1952-08-20 |
END MARKETING DATE: | 0000-00-00 |
Anectine HUMAN PRESCRIPTION DRUG Details:
Item Description | Anectine from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 1952-08-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3009_086a7742-5f8c-4127-a488-56a1cd245331 |
PRODUCT NDC: | 0781-3009 |
APPLICATION NUMBER: | NDA008453 |
Other SUCCINYLCHOLINE CHLORIDE Pharmaceutical Manufacturers / Labelers: